LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Novocure (NASDAQ: NVCR)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ NVCR Novocure
Brackmann Christoph / officer: Chief Financial Officer
07/29/2025
Buy
$11.50
5,000
$58K
141,150
NASDAQ NVCR Novocure
Brackmann Christoph / officer: Chief Financial Officer
07/29/2025
Buy
$11.60
5,000
$58K
136,150
NASDAQ NVCR Novocure
Brackmann Christoph / officer: Chief Financial Officer
07/29/2025
Buy
$11.63
10,000
$116K
131,150
NASDAQ NVCR Novocure
Puri Michal Nath / officer: Chief Human Resources Officer
06/30/2025
Buy
$15.13
833
$13K
164,514
NASDAQ NVCR Novocure
Leonard Frank X / officer: EVP, Pres., Novocure Oncology
06/30/2025
Buy
$15.13
833
$13K
348,711
NASDAQ NVCR Novocure
Danziger Asaf / director
06/30/2025
Buy
$15.13
833
$13K
416,473
NASDAQ NVCR Novocure
Cordova Ashley / officer: Chief Executive Officer
06/30/2025
Buy
$15.13
833
$13K
356,019
NASDAQ NVCR Novocure
Ben Arye Barak / officer: General Counsel
06/30/2025
Buy
$15.13
769
$12K
174,465